We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

164 hedge funds and large institutions have $454M invested in Viking Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more call options, than puts

Call options by funds: $29.3M | Put options by funds: $18M

31% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 45

26% more capital invested

Capital invested by funds: $360M → $454M (+$94.8M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.27% less ownership

Funds ownership: 65.79% → 63.51% (-2.3%)

2% less funds holding

Funds holding: 168 → 164 (-4)

13% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 30

Holders
164
Holders Change
-4
Holders Change %
-2.38%
% of All Funds
3.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
59
Reduced
45
Closed
30
Calls
$29.3M
Puts
$18M
Net Calls
+$11.3M
Net Calls Change
+$9.45M

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$6.78M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$5.87M
3
SSA
Schonfeld Strategic Advisors
New York
+$5.48M
4
Bank of America
Bank of America
North Carolina
+$5.42M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.36M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.6M
2
Citigroup
Citigroup
New York
-$7.4M
3
SFM
Sphera Funds Management
Israel
-$5.71M
4
PM
Prosight Management
Texas
-$4.77M
5
Two Sigma Investments
Two Sigma Investments
New York
-$2.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
151
IFP Advisors
Florida
$6K -$21.4K -2,558 -81%
SEI Investments
152
SEI Investments
Pennsylvania
$5K -$419K -50,102 -98%
AIS
153
Accurate Investment Solutions
Pennsylvania
$5K – – –
OIA
154
OneDigital Investment Advisors
Kansas
$5K – – –
AC
155
Avestar Capital
New York
$3K – – –
AA
156
AlphaMark Advisors
Kentucky
$2K – – –
FPFS
157
First Personal Financial Services
North Carolina
$2K – – –
RCAG
158
Rehmann Capital Advisory Group
Michigan
$1.55K – – –
S
159
SignatureFD
Georgia
$1K -$4.16K -497 -83%
CFGS
160
Concourse Financial Group Securities
Alabama
$1K -$326 -39 -25%
CAL
161
Capital Analysts LLC
Pennsylvania
$1K – – –
PFGIA
162
Patriot Financial Group Insurance Agency
Massachusetts
$1K – – –
Northwestern Mutual Wealth Management
163
Northwestern Mutual Wealth Management
Wisconsin
$1K +$636 +76 New
EWM
164
Edge Wealth Management
New York
$1K +$837 +100 +2,000%
SFM
165
Sphera Funds Management
Israel
– -$5.71M -745,727 Closed
PM
166
Prosight Management
Texas
– -$4.77M -624,000 Closed
Two Sigma Investments
167
Two Sigma Investments
New York
– -$2.98M -389,620 Closed
EI
168
EAM Investors
California
– -$1.53M -200,047 Closed
RA
169
Royce & Associates
New York
– -$1.03M -135,000 Closed
EGI
170
EAM Global Investors
California
– -$886K -115,781 Closed
UOC
171
UBS O'Connor
Illinois
– -$787K -102,842 Closed
CSS
172
Cubist Systematic Strategies
Connecticut
– -$687K -89,783 Closed
N
173
Nuveen
North Carolina
– -$635K -82,960 Closed
Millennium Management
174
Millennium Management
New York
– -$634K -82,900 Closed
SM
175
Sabby Management
Florida
– -$607K -72,500 Closed
4 5 6
7
8

VKTX Hedge Fund Activity: Q1 2019 in Review

164 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q1 2019, worth a combined $454M — up 26% from $360M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of VKTX and 26 opened new positions — a net loss of 4 holders — while 45 trimmed existing stakes and 59 added.

The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $6.78M. The largest seller was Fidelity Investments, cutting an estimated $16.6M.

  • 164 institutional investors held Viking Therapeutics (VKTX) as of Q1 2019, down from 168 in Q4 2018.
  • Funds reported $454M of Viking Therapeutics stock for Q1 2019, up 26% quarter-over-quarter.
  • 26 funds opened new Viking Therapeutics positions in Q1 2019 and 30 closed out, a net change of -4 holders.
  • The largest Viking Therapeutics buyer in Q1 2019 was Rubric Capital Management (New York), an estimated $6.78M added.
  • The largest Viking Therapeutics seller in Q1 2019 was Fidelity Investments, an estimated $16.6M sold.

Based on aggregated 13F filings for Q1 2019.